Intelligent Bio Solutions Stock Filter Stocks by Fundamentals
| INBS Stock | USD 1.39 0.08 6.11% |
Intelligent Bio Solutions fundamentals help investors to digest information that contributes to Intelligent Bio's financial success or failures. It also enables traders to predict the movement of Intelligent Stock. The fundamental analysis module provides a way to measure Intelligent Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Intelligent Bio stock.
Intelligent | Shares Owned by Institutions |
Intelligent Bio Institutional Holders
Institutional Holdings refers to the ownership stake in Intelligent Bio that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Intelligent Bio's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Intelligent Bio's value.| Shares | Hudson Bay Capital Management Lp | 2024-06-30 | 0.0 | Citigroup Inc | 2024-06-30 | 0.0 | Headlands Technologies Llc | 2024-06-30 | 0.0 | Jpmorgan Chase & Co | 2024-06-30 | 0.0 | Virtu Financial Llc | 2024-06-30 | 0.0 | Alyeska Investment Group, L.p. | 2024-09-30 | 206.2 K | Cvi Holdings Llc | 2024-06-30 | 79.8 K | Geode Capital Management, Llc | 2024-09-30 | 22.7 K | Vanguard Group Inc | 2024-09-30 | 15.5 K | Adar1 Capital Management Llc | 2024-09-30 | 5.4 K | Ubs Group Ag | 2024-09-30 | 1.6 K |
Intelligent Fundamentals
| Return On Equity | -1.72 | ||||
| Return On Asset | -0.53 | ||||
| Operating Margin | (3.86) % | ||||
| Current Valuation | 3.5 M | ||||
| Shares Outstanding | 4.39 M | ||||
| Shares Owned By Insiders | 3.01 % | ||||
| Shares Owned By Institutions | 14.38 % | ||||
| Number Of Shares Shorted | 427.41 K | ||||
| Price To Book | 1.09 X | ||||
| Price To Sales | 2.15 X | ||||
| Revenue | 3.11 M | ||||
| Gross Profit | 326.67 K | ||||
| EBITDA | (8.81 M) | ||||
| Net Income | (10.19 M) | ||||
| Cash And Equivalents | 8.28 M | ||||
| Cash Per Share | 0.56 X | ||||
| Total Debt | 871.44 K | ||||
| Current Ratio | 2.33 X | ||||
| Book Value Per Share | 2.41 X | ||||
| Cash Flow From Operations | (9.57 M) | ||||
| Short Ratio | 1.25 X | ||||
| Earnings Per Share | (2.30) X | ||||
| Target Price | 12.0 | ||||
| Number Of Employees | 50 | ||||
| Beta | 4.72 | ||||
| Market Capitalization | 6.14 M | ||||
| Total Asset | 13.78 M | ||||
| Retained Earnings | (51.96 M) | ||||
| Working Capital | 3.08 M | ||||
| Net Asset | 13.78 M |
About Intelligent Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Intelligent Bio Solutions's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Intelligent Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Intelligent Bio Solutions based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Intelligent Stock Analysis
When running Intelligent Bio's price analysis, check to measure Intelligent Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelligent Bio is operating at the current time. Most of Intelligent Bio's value examination focuses on studying past and present price action to predict the probability of Intelligent Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelligent Bio's price. Additionally, you may evaluate how the addition of Intelligent Bio to your portfolios can decrease your overall portfolio volatility.